An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials

Background: Many clinical trials with potential drug treatment options for non-alcoholic fatty liver disease (NAFLD) are focused on patients with non-alcoholic steatohepatitis (NASH) stages 2 and 3 fibrosis. As the histological features differentiating stage 1 (F1) from stage 2 (F2) NASH fibrosis ar...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diagnostics (Basel)
Auteurs principaux: Leow, Wei-Qiang, Bedossa, Pierre, Liu, Feng, Wei, Lai, Lim, Kiat-Hon, Wan, Wei-Keat, Ren, Yayun, Chang, Jason Pik-Eu, Tan, Chee-Kiat, Wee, Aileen, Goh, George Boon-Bee
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7554942/
https://ncbi.nlm.nih.gov/pubmed/32872090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10090643
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires